NCT01786707View on ClinicalTrials.gov

Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
BIOLOGICAL

Autologous stem cells

Pancreatic artery infusion of Autologous Stem cells.

OTHER

Hyperbaric oxygen therapy

DRUG

Insulin

Insulin dose as per clinical management

DRUG

Metformin

Metformin dose as tolerated

Trial Locations (1)

33136

Diabetes Research Institute, University of Miami Miller School of Medicine, Miami

Sponsors
All Listed Sponsors
collaborator

Diabetes Research Institute Foundation

OTHER

lead

Rodolfo Alejandro

OTHER